Nanomedicine News

RSS

Alumnus' Gift to Advance the Field of Biologically Inspired Engineering

Engineer, entrepreneur, and philanthropist Hansjörg Wyss MBA '65 has given Harvard University $125 million to create the Hansjörg Wyss Institute for Biologically Inspired Engineering.

9 Oct 2008

Rice Leads Nation in Industry Impact for Quality of its Nanotechnology Patents

Rice University has leapt to the forefront of American research universities for the impact on industry of its accumulated patents, according to a company that analyzes intellectual property. The Patent Board, a Chica...

9 Oct 2008

RNA Molecules Significantly Bolster Vaccine's Effectiveness

A novel delivery system that could lead to more efficient and more disease-specific vaccines against infectious diseases has been developed by biomedical engineers at The University of Texas at Austin.

9 Oct 2008

Using Cells as Factories to Make DNA Based Nanostructures

In the tiny realm of nanotechnology, scientists have used a wide variety of materials to build atomic scale structures. But just as in the construction business, nanotechnology researchers can often be limited by the amo...

9 Oct 2008

Applied Nanotech Announces License Agreement With Prominent Sporting Goods Manufacturer

Applied Nanotech Holdings, Inc. announced that as a result of the success of the joint research program of the companies, it has entered into a license agreement with a prominent sporting goods manufacturer covering Appl...

From Nano Magic, LLC. 9 Oct 2008

Scientists Awarded 2008 Nobel Prize in Chemistry for Discovery and Development of GFP

The Royal Swedish Academy of Sciences has decided to award the Nobel Prize in Chemistry for 2008 jointly to Osamu Shimomura, Martin Chalfie, and Roger Y. Tsien, for the discovery and development of the green fluorescent protein, GFP.

8 Oct 2008

Applied Nanotech Expands Research Agreement

Applied Nanotech Holdings, Inc. today announced that the third phase of its research project with a leading industrial chemical products company in Japan, announced on September 29, 2008, has been expanded and the previo...

From Nano Magic, LLC. 8 Oct 2008

Particle Sciences Sells Proprietary Line of Microfine Titanium Dioxide to Sensient

Particle Sciences announced today that it has sold T-COTE, its proprietary line of microfine titanium dioxide, to Sensient. With the sale, Sensient assumes all marketing and sales responsibilities and acquires the associ...

8 Oct 2008

Using Carbon Nanospheres to Produce an Improved Imaging Agent

Luna Innovations Incorporated announces an award from the National Cancer Institute (NCI) of the National Institutes of Health (NIH) to improve the detection and diagnosis of brain tumors. Under this program, Luna will a...

8 Oct 2008

NCCN Announces Collaboration to Conduct Anti-Cancer Drug Studies

The National Comprehensive Cancer Network (NCCN), Abraxis BioScienc, and AstraZeneca today announced that they have entered into a collaboration to conduct multiple investigator-initiated studies of Abraxis BioScience's anti-cancer drug ABRAXANE® for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin bound), which is based on the company's proprietary tumor targeting technology known as the nab(TM) platform.

8 Oct 2008